Efficacy and complications of adalimumab treatment for medically-refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004-2008)-Reference-Cited by-同舟云学术

Efficacy and complications of adalimumab treatment for medically-refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004-2008)

Published:2009-03 Issue:5 Volume:29 Page:527-534
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

HO G. T.,MOWAT A.,POTTS L.,CAHILL A.,MOWAT C.,LEES C. W.,HARE N. C.,WILSON J. A.,BOULTON-JONES R.,PRIEST M.,WATTS D. A.,SHAND A. G.,ARNOTT I. D.,RUSSELL R. K.,WILSON D. C.,MORRIS A. J.,SATSANGI J.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2008.03919.x/fullpdf

Reference31 articles.

1. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet JID - 2985213R,2002

2. Infliximab for the treatment of fistulas in patients with Crohn’s disease;Present;N Engl J Med JID - 0255562,1999

3. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study;Jarnerot;Gastroenterology,2005

4. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

5. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial;Sandborn;Ann Intern Med,2007

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perforated jejunal diverticulitis in the setting of biologic therapy presenting as transverse Colon diverticulitis: A case report;International Journal of Surgery Case Reports;2024-05

2. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01

3. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review;Cancers;2023-07-27

4. Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?;Journal of Clinical Medicine;2021-11-15

5. Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis;Journal of Clinical Medicine;2021-05-14